Visits: 1580, Avg visit time (secs): 236,83 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 686 | 43,42% | |
| /programmes.html | 148 | 9,37% |
| /novartis/efsd-novartis-rfa09.html | 113 | 7,15% |
| /msd/basic/efsd-msd-basic-rfa09.html | 103 | 6,52% |
| /efsd-grant/efsd-clinresgrant-rfa08.html | 97 | 6,14% |
| /msd/clinical/efsd-msd-clinical-rfa09.html | 41 | 2,59% |
| /efsd-grant/efsd-clinresgrant-rfa09.html | 37 | 2,34% |
| /msd/albert-renold/efsd-msd-arenold.html | 28 | 1,77% |
| /regulations.html | 27 | 1,71% |
| /lilly/programme/efsd-lilly-cds-fellowship08.html | 21 | 1,33% |
| /amylin/efsd-amylin-rfa08.html | 19 | 1,20% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 773 | 48,92% |
| /novartis/efsd-novartis-rfa09.html | 194 | 12,28% |
| /msd/basic/efsd-msd-basic-rfa09.html | 69 | 4,37% |
| /home.html | 47 | 2,97% |
| /msd/clinical/efsd-msd-clinical-rfa09.html | 41 | 2,59% |
| /efsd-grant/efsd-clinresgrant-rfa08.html | 31 | 1,96% |
| /msd/albert-renold/efsd-msd-arenold.html | 31 | 1,96% |
| /dcure/efsd-dcure-rfa08.html | 31 | 1,96% |
| /programmes.html | 29 | 1,84% |
| /new_horizons/new-horizons09.html | 28 | 1,77% |
| /gsk/efsd-gsk-rfa08.html | 27 | 1,71% |